OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Causal effect of COVID‐19 on Alzheimer's disease: A Mendelian randomization study
Ancha Baranova, Hongbao Cao, Fuquan Zhang
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 57

Computational Network Analysis of Two Popular Skin Cancers Provides Insights into the Molecular Mechanisms and Reveals Common Therapeutic Targets
M A Mahmud, Bikash Kumar Paul, Md Rakibul Hasan, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41688-e41688
Open Access

VIBE: an R-package for VIsualization of Bulk RNA Expression data for therapeutic targeting and disease stratification
Indu Khatri, Saskia D. van Asten, Leandro F. Moreno, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access

A druggable targets discovery strategy for diseases (DTDS): Taking Rheumatoid arthritis as a case
Chaoqun Liu, Shuai Zhao, Liansheng Qiao, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114182-114182
Closed Access

Gene network analysis identifies dysregulated pathways in an autism spectrum disorder caused by mutations in Transcription Factor 4
Lucas Miguel de Carvalho, Vinicius Miessler de Andrade Carvalho, Antônio Pedro Camargo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
Daniela Milani, Lorenzo Caruso, Enrico Zauli, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26

The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
Aliakbar Hasankhani, Abolfazl Bahrami, Bahareh Tavakoli‐Far, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13

Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing
Md. Ariful Islam, Md. Kaderi Kibria, Md. Bayazid Hossen, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10

Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study
Daniele Mengato, Maria Mazzitelli, Andrea Francavilla, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 6, pp. 2749-2756
Open Access | Times Cited: 9

Genetic overlap and causality between COVID-19 and multi-site chronic pain: the importance of immunity
Yanjing Chen, Ping Liu, Zhiyi Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension
Jason Hong, Lejla Medzikovic, Wasila Sun, et al.
Circulation (2024) Vol. 150, Iss. 16, pp. 1268-1287
Closed Access | Times Cited: 2

Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19
Qiying Jin, Wanxi Li, Wendi Yu, et al.
Computers in Biology and Medicine (2022) Vol. 150, pp. 106134-106134
Open Access | Times Cited: 12

Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study
Martin Grumet, Jason Sherman, Barry S Dorf
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 11, pp. 1103-1112
Open Access | Times Cited: 12

Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature
Sara Redenšek, David Vogrinc, Katja Goričar, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 6

Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors
Mallikarjuna Rao Gedda, Patrick Danaher, Lipei Shao, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 11

Navigating the Gene Co-Expression Network and Drug Repurposing Opportunities for Brain Disorders Associated with Neurocognitive Impairment
Mathew Timothy Artuz Manuel, Lemmuel L. Tayo
Brain Sciences (2023) Vol. 13, Iss. 11, pp. 1564-1564
Open Access | Times Cited: 5

Increase in venous thromboembolism in SARS‐CoV‐2 infected lung tissue: proteome analysis of lung parenchyma, isolated endothelium, and thrombi
Boaz Lopuhaä, Coşkun Güzel, Anabel van der Lee, et al.
Histopathology (2024) Vol. 84, Iss. 6, pp. 967-982
Open Access | Times Cited: 1

Blueprint of differentially expressed genes reveals the dynamic gene expression landscape and the gender biases in long COVID
Chiranjib Chakraborty, Manojit Bhattacharya, Abdulrahman Alshammari, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 5, pp. 748-766
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top